Coordinate production of PGE2 and IL-1β in the gingival crevicular fluid of adults with periodontitis: Its relationship to alveolar bone loss and disruption by twice daily treatment with ketorolac tromethamine oral rinse

Journal of Periodontal Research

Volumn 33, Issue 2, 1998, Pages 75-82

  Cavanaugh Jr , P F ^a,c   Meredith, M P ^a   Buchanan, W ^a   Doyle, M J ^a   Reddy, M S ^b   Jeffcoat, M K ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

Bone; Interleukin 1 ; Ketorolac; Periodontitis; Prostaglandin

Indexed keywords

DRUG DERIVATIVE; INTERLEUKIN 1; KETOROLAC TROMETAMOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; TOLMETIN; TROMETAMOL;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; CHEMISTRY; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; FEMALE; GINGIVITIS; HUMAN; IMAGE SUBTRACTION; MALE; METABOLISM; MIDDLE AGED; MOUTH HYGIENE; OSTEOLYSIS; PERIODONTITIS; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

ADULT; ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DINOPROSTONE; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN-1; KETOROLAC TROMETHAMINE; LINEAR MODELS; MALE; MIDDLE AGED; MOUTHWASHES; PERIODONTITIS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; SUBTRACTION TECHNIQUE; TOLMETIN; TROMETHAMINE;

EID: 0031995419     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1998.tb02295.x     Document Type: Article

References (27)

1. 2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986; 21: 101-112.
2. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993; 64: 432-444.
3. Masada MP, Persson R, Kenney JS, Lee SW, Page RC, Allison AC. Measurement of interleukin-1α and -1β in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J Periodont Res 1990; 25: 156-163.
4. Herschman HR. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metast Rev 1994; 13: 241-256.
5. Cavanaugh PF Jr, McDonald JS, Pavelic L, Limardi RJ, Gluckman JL, Pavelic ZP. Immunohistochemical localization of prostaglandin H synthase isoenzyme proteins in the gingival tissue of patients with periodontitis. Inflammopharmacol 1995; 3: 109-119.
6. Jandiski JJ, Stashenko P, Feder LS, et al. Localization of interleukin-1β in human periodontal tissue. J Periodontol 1991; 62: 36-43.
7. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of interleukin-1β in tissue from sites of active periodontal disease. J Clin Periodontol 1991; 18: 548-554.
8. Kornman KS, Carane A, Wang H-Y, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997; 24: 72-77.
9. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993; 64: 474-484.
10. 2 levels of human synovial cells. Arthritis Rheum 1987; 30: 562-566.
11. Page R. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 1991; 26: 230-42.
12. Vane JR, Botting RM. A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2). Adv Prostaglandin Thrombox Leukot Res 1995; 23: 41-48.
13. Wahl LM, Lampel LL. Regulation of human peripheral blood monocyte collagenase by prostaglandins and anti-inflammatory drugs. Cell Immunol 1987; 105: 411-422.
14. Wahl LM, Corcoran ML. Regulation of monocyte/ macrophage metalloproteinase production by cytokines. J Periodontol 1993; 64: 467-473.
15. Zyglcwska T, Sanduja R, Ohashi K, Loos-Mitchell DS, Sanduja S, Wu KK. Inhibition of endothelial cell prostaglandin H synthase gene expression by naproxen. Biochim Biophys Acta 1992; 1131: 78-82.
16. Williams RC, Jeffcoat MK, Howell TH, et al. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989; 60: 485-490.
17. Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK. Efficacy of meclofenamate sodium (MECLOMEN) in the treatment of rapidly progressive periodontitis. J Clin Periodontol 1993; 20: 635-640.
18. Jeffcoat MK, Page R, Reddy M, et al. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodont Res 1991; 26: 415 421.
19. Jeffcoat MK, Reddy MS, Haigh S, et al. A comparison of topical ketorolac, systemic flurbiprofen, placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 1995; 66: 329-338.
20. Jeffcoat MK, Williams RC, Holman L, English R, Goldhaber P. Detection of active bone bone loss in human periodontal disease by a single evaluation of 99 m-Tc-MDP uptake. J Dent Res 1986; 65: 176 (Abst. No. 58).
21. Jeffcoat MK, Reddy MS, Webber RL, Williams RC, Ruttimann UE. Extraoral control of geometry for digital substraction radiography. J Periodont Res 1987; 22: 396-402.
22. Ruttimann UE, Webber RL, Schmidt E. A robust digital method for film contrast correction in subtraction radiography. J Periodont Res 1986; 21: 486-495.
23. Machtei EE, Norderyd J, Koch G, Dunford R, Grossi S, Genco RJ. The rate of periodontal attachment loss in subjects with established periodontitis. J Periodontol 1993; 64: 713-718.
24. Allison AC, Chin R-C, Cheng Y. Cyclooxygenase inhibitors vary widely in potency for preventing cytokine-induced bone resorption. Ann NY Acad Sci 1993; 696: 303-306.
25. Grossi SG, Genco RJ, Machtei EE, et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 1995; 66: 23-29.
26. Hausmann E, Allen K, Norderyd J, Ren W, Shibly O, Machtei E. Studies on the relationship between changes in radiographic bone height and probing attachment. J Clin Periodont 1994; 21: 128-132.
27. 2 with ketorolac rinses. J Dent Res 1994; 73 (SI-AADR Abstracts): No. 125.